BLOOMINGTON, IN—Researchers at Indiana University have identified new biomarkers that may advance the early detection of diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in U.S. adults.
- ST. LOUIS, MO—An assistant professor at the McKelvey School of Engineering at Washington University in St. Louis will be leading a three-year research initiative to accelerate the development of the next generation of imaging technologies. Ulugbek Kamilov has already designed algorithms to shave time off of MRI scans and worked on software aimed at tailoring unwieldy amounts of data into manageable datasets.
- INDIANAPOLIS, IN—An experimental eczema medicine from Eli Lilly called lebrikizumab has succeeded in two late-stage clinical trials. The drug was developed by Dermira, a company Lilly acquired in 2019 for just over $1 billion.